Versant Venture Management, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 80 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Versant Venture Management, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$7,602,350
-5.7%
5,068,2330.0%4.04%
-57.7%
Q2 2023$8,058,490
+121.6%
5,068,2330.0%9.56%
+26.1%
Q1 2023$3,635,950
+23.8%
5,068,2330.0%7.58%
+24.7%
Q4 2022$2,937,041
-39.0%
5,068,2330.0%6.08%
-26.0%
Q3 2022$4,815,000
-20.8%
5,068,2330.0%8.21%
-12.0%
Q2 2022$6,082,000
-8.4%
5,068,2330.0%9.32%
+40.7%
Q1 2022$6,639,000
-25.6%
5,068,2330.0%6.63%
+38.9%
Q4 2021$8,920,000
-18.9%
5,068,2330.0%4.77%
+4.8%
Q3 2021$10,998,000
-38.0%
5,068,2330.0%4.55%
-22.5%
Q2 2021$17,739,000
-64.5%
5,068,2330.0%5.88%
-39.6%
Q1 2021$49,973,000
-7.9%
5,068,233
+1.3%
9.74%
+72.8%
Q4 2020$54,242,000
-24.8%
5,003,892
-28.6%
5.63%
-57.3%
Q3 2020$72,140,000
-100.0%
7,003,8920.0%13.20%
-37.2%
Q2 2020$146,241,265,000
+111.8%
7,003,892
-0.9%
21.01%
+10.9%
Q1 2020$69,056,636,0007,068,23318.94%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$17,739,0005.88%
Sonic Fund II, L.P. 6,552,068$22,932,0001.69%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$1,680,0000.88%
Avoro Capital Advisors LLC 6,950,000$24,325,0000.42%
RTW INVESTMENTS, LP 7,357,917$25,753,0000.39%
K2 PRINCIPAL FUND, L.P. 898,307$3,144,0000.26%
Artal Group S.A. 3,000,000$10,500,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,827,000$9,895,0000.18%
WS MANAGEMENT LLLP 307,442$1,076,0000.11%
ALGERT GLOBAL LLC 82,145$288,0000.10%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders